HealthVerity taXonomy webinar recap: Claim better outcomes
As the industry develops increasingly complex treatments to address unmet clinical needs, it is...
As the industry develops increasingly complex treatments to address unmet clinical needs, it is...
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
This is part two of a three-part series on the essential qualities of claims data for life sciences research. If you missed part one, we covered the importance of comprehensive claims data. Next up: how curated data enhances analytical precision and ...